[go: up one dir, main page]

NO983672L - Prevention system with antibacterial and / or antiviral effect - Google Patents

Prevention system with antibacterial and / or antiviral effect

Info

Publication number
NO983672L
NO983672L NO983672A NO983672A NO983672L NO 983672 L NO983672 L NO 983672L NO 983672 A NO983672 A NO 983672A NO 983672 A NO983672 A NO 983672A NO 983672 L NO983672 L NO 983672L
Authority
NO
Norway
Prior art keywords
antibacterial
antiviral effect
prevention system
compound
release system
Prior art date
Application number
NO983672A
Other languages
Norwegian (no)
Other versions
NO983672D0 (en
Inventor
Ckemann Klaus St
Arwed Cleve
Karin Hoffmann
Ulrich Koch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO983672D0 publication Critical patent/NO983672D0/en
Publication of NO983672L publication Critical patent/NO983672L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Kombinasjonen av minst en forbindelse med preventiv effekt og/eller en forbindelse med antibakteriell effekt og/eller antiviruseffekt til innarbeidelse i/anbringelse på av et intravaginalt, intrauterint eller intracervikalt frigjøringssystem, og anvendelse av et slikt frigjøringssystem.The combination of at least one compound having a preventive effect and / or a compound having antibacterial and / or antiviral effect for incorporation into / application to an intravaginal, intrauterine or intracervical release system, and use of such a release system.

NO983672A 1996-02-12 1998-08-11 Prevention system with antibacterial and / or antiviral effect NO983672L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19606355A DE19606355A1 (en) 1996-02-12 1996-02-12 Contraceptive release systems with antiviral and / or antibacterial effects
PCT/DE1997/000321 WO1997028826A2 (en) 1996-02-12 1997-02-11 Contraceptive release systems with antibacterial and/or antiviral effect

Publications (2)

Publication Number Publication Date
NO983672D0 NO983672D0 (en) 1998-08-11
NO983672L true NO983672L (en) 1998-10-09

Family

ID=7785948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983672A NO983672L (en) 1996-02-12 1998-08-11 Prevention system with antibacterial and / or antiviral effect

Country Status (21)

Country Link
EP (1) EP0880364A2 (en)
JP (1) JP2000506515A (en)
KR (1) KR19990082434A (en)
CN (1) CN1211193A (en)
AP (1) AP9801306A0 (en)
AU (1) AU2379297A (en)
BG (1) BG102682A (en)
BR (1) BR9707416A (en)
CA (1) CA2245920A1 (en)
CZ (1) CZ253298A3 (en)
DE (1) DE19606355A1 (en)
EA (1) EA199800714A1 (en)
EE (1) EE9800239A (en)
HU (1) HUP9901977A3 (en)
IL (1) IL125481A0 (en)
IS (1) IS4802A (en)
NO (1) NO983672L (en)
PL (1) PL328333A1 (en)
SK (1) SK107098A3 (en)
TR (1) TR199801551T2 (en)
WO (1) WO1997028826A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU757649B2 (en) * 1998-09-10 2003-02-27 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
AU2003213958A1 (en) * 2002-04-03 2003-10-13 Jencap Research Ltd. Female birth control method
NZ564398A (en) * 2005-06-24 2011-11-25 Biotron Ltd 2-Naphthoyl-guanidine derivatives as antiviral agents
DE102008006416A1 (en) * 2008-01-28 2009-07-30 Mayer, Thomas, Dr. med. Clindamycin or its salt, or a clindamycin-containing composition useful for the intracervical or endocervical treatment or prevention of bacterial vaginosis caused by anaerobic and gram positive aerobic germs
KR20110045065A (en) * 2008-09-16 2011-05-03 플레이텍스 프로덕츠, 엘엘씨. Drugs for menstrual suppression, contraception and hormone replacement therapy and methods of administering the same
FI20095563A7 (en) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginal delivery system
GB201203768D0 (en) * 2012-03-05 2012-04-18 John Richard W Medical device
CA2873222A1 (en) * 2014-06-28 2015-12-28 German Arzobindo Campos Perez Cerclage pessary containing progesterone of prolonged, sustained, and continuous release useful for prevention of preterm birth
CN105796572A (en) * 2014-08-25 2016-07-27 郭曙平 Contraceptive and preparation method thereof
CN109248140A (en) * 2017-07-14 2019-01-22 国家卫生计生委科学技术研究所 The preparation method and application of progesterone antibacterial pesseulum
EP3446664A1 (en) 2017-08-21 2019-02-27 Karl-Heinz Kurz Intrauterine device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3656483A (en) * 1970-01-15 1972-04-18 Biolog Concepts Inc Intrauterine medicator
US4180064A (en) * 1972-12-27 1979-12-25 Alza Corporation System for delivering agent to environment of use over prolonged time
FR2250520B1 (en) * 1973-11-09 1977-04-15 Cournut Rene
US4034749A (en) * 1973-12-06 1977-07-12 Schering Aktiengesellschaft Intrauterine contraceptive device
US4393871A (en) * 1977-06-27 1983-07-19 Vli Corporation Vaginal device
GB2026320A (en) * 1978-07-25 1980-02-06 Gutnick Morton Devices for the prevention of venereal disease
US4578076A (en) * 1984-03-20 1986-03-25 The Population Council, Inc. Medicated intracervical and intrauterine devices
US5229423A (en) * 1992-03-06 1993-07-20 Albert Einstein College Of Medicine Of Yeshiva University Use of butylurea as a contraceptive agent

Also Published As

Publication number Publication date
BR9707416A (en) 1999-05-25
EA199800714A1 (en) 1999-02-25
NO983672D0 (en) 1998-08-11
EP0880364A2 (en) 1998-12-02
HUP9901977A3 (en) 2000-06-28
WO1997028826A2 (en) 1997-08-14
JP2000506515A (en) 2000-05-30
DE19606355A1 (en) 1997-08-14
HUP9901977A2 (en) 1999-10-28
CA2245920A1 (en) 1997-08-14
KR19990082434A (en) 1999-11-25
IS4802A (en) 1998-07-21
IL125481A0 (en) 1999-03-12
CN1211193A (en) 1999-03-17
BG102682A (en) 1999-03-31
CZ253298A3 (en) 1999-01-13
WO1997028826A3 (en) 1997-10-16
TR199801551T2 (en) 1998-11-23
EE9800239A (en) 1998-12-15
AP9801306A0 (en) 1998-09-30
SK107098A3 (en) 1999-01-11
PL328333A1 (en) 1999-01-18
AU2379297A (en) 1997-08-28

Similar Documents

Publication Publication Date Title
MX9201235A (en) PROCEDURE FOR THE MANUFACTURE OF DISPERSIBLE BOEHMITA.
DE3486409D1 (en) Composition for the controlled release of an active ingredient.
ZA981936B (en) Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
FI935893A7 (en) Controlled release system and low-dose androgens
FI844799A7 (en) Active ingredient release system.
BG100960A (en) DOSAGE FORMS WITH CONTROLLED RELEASE OF ASITROMYCIN
FI941396A0 (en) Compositions for the controlled release of biologically active TGF
MX9201994A (en) S, S-DIOXIDES OF BENZO TIOFEN -2- CARBOX AMIDA AND PROCEDURE FOR ITS OBTAINING.
GR3035574T3 (en) Use of substituted benzimidazoles.
NO983672L (en) Prevention system with antibacterial and / or antiviral effect
TR27916A (en) Preparation and method for cleaning oxygen.
TR199900505T2 (en)
DE69919179D1 (en) SUBSTITUTED GAMMA-PHENYL-DELTA-LACTONE AND THEIR ANALOGS, AND THEIR USE
MX9203070A (en) COMPOUNDS WITH RENINE INHIBITING PROPERTIES, PROCEDURE FOR THEIR PREPARATION AND USE.
SE8505121D0 (en) immuno
DE69024047D1 (en) Nimbaumöl containing composition for fertility control and for the prevention of pregnancy.
FI955161L (en) Systems for controlled release of pilocarpine
MX9206482A (en) 1,5-SUBSTITUTED PENTANODIOLS AND PROCESSES FOR THE PREPARATION OF THE SAME
FR2630844B1 (en) PROTECTION SYSTEM FOR PERSONS AGAINST ASSAULT
BR9612245A (en) Nitric oxide (no) synthase inhibitor for treatment or prevention of type ii diabetes
DK0809435T3 (en) Composition suitable for acrole release and its use
PT1017377E (en) UTILIZATION OF 6,7-SUBSTITUTED 2-AMINOTETRALINS FOR THE TREATMENT OF CYLOCHINE-MEDIATED INFLAMMATORY CONDITIONS
KR900007413A (en) Prevention of AIDS, treatment and composition for the treatment
HUT62106A (en) Circuit arrangement for transferring signals of digital state indicating units, especially sensors of protection of poperty and/or protection against fire
KR930008623U (en) Locking system for cold and cold towers

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application